The Horizon Europe funded project ASCERTAIN invites you to the webinar “How do different countries make decisions on reimbursing new medicines?” The webinar will take place on Wednesday 2nd April 2025, from 16:00 to 17:30 CET. 

The webinar will be given by Tom Belleman, PhD candidate at the Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam, who will deliver a 45-minute presentation, followed by a 30-minute Q&A session to address your questions. Registration is free of charge.

If you are interested in attending or know someone who might benefit from this session, please forward the registration link. If you are unable to attend live, we welcome you to send your questions in advance to info@mpeurope.org, and we will make sure they reach our speaker.

Meet the expert

Tom Belleman is a PhD candidate at the Erasmus School of Health Policy and Management (ESHPM) Erasmus University Rotterdam, within the Health Technology Assessment (HTA) department. His research focuses on cost-effectiveness and market access/reimbursement of innovative health technologies, particularly in the field of oncology.

Tom holds a Bachelor’s degree in Biomedical Sciences from Vrije Universiteit Amsterdam and a Master’s degree in Health Economics, Policy & Law from Erasmus University Rotterdam.

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them. Grant agreement 101094938.